BCYC

Bicycle Therapeutics plc

BCYC · CIK 1761612 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$35M
20192024
Net Income−$169M
20192024
Operating CF−$165M
20192024
Free Cash Flow−$166M
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.2B$0.2B$0.1B$0.0B$0.0B$0.0B
SG&A Expense——————
Operating Income$-0.2B$-0.2B$-0.1B$-0.1B$-0.1B$-0.0B
Net Income$-0.2B$-0.2B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-2.90$-5.08$-3.80$-2.67——
EPS (Diluted)$-2.90$-5.08$-3.80$-2.67——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$1.0B$0.6B$0.4B$0.5B$0.2B$0.1B
Current Assets$0.9B$0.6B$0.4B$0.5B$0.2B$0.1B
Cash & Equivalents$0.9B$0.5B$0.3B$0.4B$0.0B$0.0B
Total Liabilities$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.8B$0.4B$0.3B$0.3B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.2B$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.5B$0.3B$0.0B$0.3B$0.1B$0.1B
← Companies